Status:
COMPLETED
The Role of Obesity in Peri-Implant Health(ROPIPH)
Lead Sponsor:
Mine Keskin
Conditions:
Obesity &Amp; Overweight
Peri Implantitis
Eligibility:
All Genders
18-65 years
Brief Summary
This clinical study aims to evaluate the influence of obesity on peri-implant health. Both clinical parameters and biochemical markers in peri-implant crevicular fluid(PICF) will be assessed. The stud...
Detailed Description
This prospective clinical study investigates the role of obesity in peri-implant health by assessing both clinical and biochemical parameters. The study population will consist of systemically healthy...
Eligibility Criteria
Inclusion
- Adults ≥18 years with dental implants in function for at least 1 year.
- Patients diagnosed with peri-implantitis according to clinical and radiographic criteria.
- For control group: systemically healthy individuals with peri-implant health.
- Written informed consent obtained.
Exclusion
- Patients with systemic diseases affecting periodontal/implant health (e.g., uncontrolled diabetes, HIV, cardiovascular disease, kidney disorders).
- Pregnant or lactating women.
- Current smokers or individuals using smokeless tobacco.
- Alcohol abuse.
- Use of antibiotics or anti-inflammatory drugs within the last 3 months.
- Patients who had received peri-implant treatment within the last 6 months.
Key Trial Info
Start Date :
February 12 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 29 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT07183163
Start Date
February 12 2023
End Date
October 29 2024
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Recep Tayyip Erdoğan University Faculty of Dentistry, Department of Periodontology
Rize, Turkey (Türkiye), 53020